Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 13, 2024

Association Between HER2-Low Status and Survival Outcomes in Patients With Metastatic Breast Cancer Treated With CDK4/6 Inhibitors

Breast Cancer Research and Treatment


Additional Info

Breast Cancer Research and Treatment
The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis
Breast Cancer Res Treat 2024 Jan 19;[EPub Ahead of Print], DC Guven, TK Sahin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading